ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 395 out of 2888

$622K Total Retail Price of All Prescriptions

Rank: 586 out of 2888

479 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

47% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 7,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 734 377 S3 1 4
ACETAMINOPHEN-CODEINE 666 325 S3 10 2 147
FUROSEMIDE 404 304 3 6
SIMVASTATIN 350 243 4 2
AMLODIPINE BESYLATE 320 208 5 5
LISINOPRIL 302 230 6 3
METOPROLOL TARTRATE 235 141 7 10
AMOXICILLIN 215 148 8 117
NEXIUM 208 127 9 19
POTASSIUM CHLORIDE 201 147 10 14
METFORMIN HCL 157 115 11 8
AZOR 155 122 12 320
METHOCARBAMOL 154 56 R 13 176
AGGRENOX 153 140 14 223
ZOLPIDEM TARTRATE 151 44 15 17
CARVEDILOL 148 111 16 21
PREDNISONE 142 80 17 42
LEVOTHYROXINE SODIUM 134 87 18 1
CEFUROXIME 128 79 19 130
CLONIDINE HCL 125 30 20 39
NAPROXEN 124 37 21 80
CRESTOR 123 96 22 20
DONEPEZIL HCL 112 102 23 26
BUSPIRONE HCL 106 62 24 148
ALLOPURINOL 105 96 25 37
TRAMADOL HCL 101 42 26 16
AMLODIPINE BESYLATE-BENAZEPRIL 101 84 26 67
GABAPENTIN 99 56 28 13
TAMSULOSIN HCL 97 79 29 29
OMEPRAZOLE 94 74 30 7
HYDROCHLOROTHIAZIDE 91 55 31 15
IBUPROFEN 90 63 32 87
GLYBURIDE 89 62 R 33 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 63 33 28
BENAZEPRIL HCL 87 79 35 77
NOVOLIN 70-30 86 39 36 144
SINGULAIR 84 59 37 85
LOVASTATIN 82 74 38 41
CLOPIDOGREL 78 48 39 30
CITALOPRAM HBR 74 38 40 24
DILTIAZEM HCL 73 28 41 236
ESCITALOPRAM OXALATE 73 42 41 62
LEVOCETIRIZINE DIHYDROCHLORIDE 71 54 43 220
METOPROLOL SUCCINATE 69 52 44 11
TRIAMTERENE-HCTZ 68 67 45 63
INSULIN SYRINGE 67 35 46 86
PLAVIX 65 42 47 40
COLCRYS 61 46 48 295
RANITIDINE HCL 61 40 48 56
METOCLOPRAMIDE HCL 60 31 50 116
WARFARIN SODIUM 58 58 51 22
MEGESTROL ACETATE 58 53 R 51 140
GLYBURIDE-METFORMIN HCL 57 45 R 53 64
BENICAR 57 42 53 138
HYDRALAZINE HCL 55 31 55 59
PREMARIN 52 35 R 56 129
SERTRALINE HCL 50 37 57 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.